Geerwin Yvonne Paul Haché

USPTO Granted Patents = 15 (Patent Applications = 3)

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 73(Granted Patents)

Location History:

Brasschaat, BE (2009)
Mechelen, BE (2013)
Kapellan, BE (2020)
Kapellen, BE (2014 - 2021)

Company Filing History:

11 out of 111

Janssen Sciences Ireland Uc

Janssen Sciences Ireland Unlimited Company

patents

4. 1 out of 66

Tibotec Pharmaceuticals Ltd.

patents

Years Active: 2009-2021

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11096931 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases (2021-08-24),

2. 11078193 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2021-08-03),

3. 10875876 - Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2020-12-29),

4. 10457638 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2019-10-29),

5. 10398677 - N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2019-09-03),

6. 10377709 - Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2019-08-13),

7. 10160743 - Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2018-12-25),

8. 10071961 - Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2018-09-11),

9. 9895349 - N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2018-02-20),

10. 9884818 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2018-02-06),

11. 9567299 - Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2017-02-14),

12. 9233933 - 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B (2016-01-12),

13. 8664391 - Amide compounds as boosters of antivirals (2014-03-04),

14. 8350048 - Amide compounds as boosters of antivirals (2013-01-08),

15. 7615639 - 1-pyridyl-benzofuro[3,2-b]pyridin-2(1H)-ones (2009-11-10),

Title: Geerwin Yvonne Paul Haché: Pioneering Innovator in HBV Treatment

Introduction:

Geerwin Yvonne Paul Haché, a remarkable inventor hailing from Kapellen, BE, is a true testament to the power of innovation and individual impact. With a strong dedication to progress and a relentless inventive spirit, Haché has revolutionized the field of hepatitis B virus (HBV) treatment through his groundbreaking patents and contributions.

Latest Patents:

Haché's ingenuity shines through in his latest patents, which focus on amide derivatives and sulphamoylpyrrolamide derivatives for the treatment of HBV infection. The applications encompass processes for preparation, pharmaceutical compositions, and the therapeutic use of these compounds in combatting chronic HBV infection, showcasing Haché's commitment to advancing medical science.

Career Highlights:

Having amassed an impressive portfolio of 15 patents, Haché's expertise has been instrumental in the development of innovative solutions for HBV treatment. Notably, he has made significant contributions during his tenure at Janssen Sciences Ireland Uc and Janssen Research & Development Ireland, showcasing his pivotal role in advancing medical research and development.

Collaborations:

Haché's collaborative spirit is evident through his partnerships with esteemed colleagues such as Koen Vandyck and Pierre Jean-Marie Bernard Raboisson. Together, they have worked tirelessly to push the boundaries of HBV therapy, further underscoring Haché's collaborative approach to driving impactful inventions.

Conclusion:

In conclusion, Geerwin Yvonne Paul Haché stands as a beacon of innovation and progress in the field of HBV treatment. His pioneering patents and dedication to advancing medical science have not only shaped the landscape of HBV therapy but have also paved the way for future breakthroughs in the field. Haché's legacy as an inventive trailblazer continues to inspire generations of inventors to push the boundaries of what is possible in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.